1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Opioid Drugs Market
2.2. Global Opioid Drugs Market, By Drug, 2023 (US$ Million)
2.3. Global Opioid Drugs Market, By Application, 2023 (US$ Million)
2.4. Global Opioid Drugs Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023

3. Opioid Drugs Market: Competitive Analysis
3.1. Market Positioning of Key Opioid Drugs Market Vendors
3.2. Strategies Adopted by Opioid Drugs Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2032

4. Opioid Drugs Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Opioid Drugs Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Opioid Drugs Market: By Drug, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Morphine
5.3.2. Methadone
5.3.3. Codeine
5.3.4. Oxycodone
5.3.5. Meperidine
5.3.6. Fentanyl
5.3.7. Others

6. Opioid Drugs Market: By Application, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Pain Management
6.3.2. Cough Suppressant
6.3.3. Diarrhea
6.3.4. Anesthesia


7. North America Opioid Drugs Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Opioid Drugs Market: By Drug, 2022-2032, USD (Million)
7.3. Opioid Drugs Market: By Application, 2022-2032, USD (Million)
7.4.Opioid Drugs Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Opioid Drugs Market: By Drug, 2022-2032, USD (Million)
7.4.1.1.2. Opioid Drugs Market: By Application, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Opioid Drugs Market: By Drug, 2022-2032, USD (Million)
7.4.1.2.2. Opioid Drugs Market: By Application, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Opioid Drugs Market: By Drug, 2022-2032, USD (Million)
7.4.1.3.2. Opioid Drugs Market: By Application, 2022-2032, USD (Million)

8. UK and European Union Opioid Drugs Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Opioid Drugs Market: By Drug, 2022-2032, USD (Million)
8.3. Opioid Drugs Market: By Application, 2022-2032, USD (Million)
8.4.Opioid Drugs Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Opioid Drugs Market: By Drug, 2022-2032, USD (Million)
8.4.1.1.2. Opioid Drugs Market: By Application, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Opioid Drugs Market: By Drug, 2022-2032, USD (Million)
8.4.1.2.2. Opioid Drugs Market: By Application, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Opioid Drugs Market: By Drug, 2022-2032, USD (Million)
8.4.1.3.2. Opioid Drugs Market: By Application, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Opioid Drugs Market: By Drug, 2022-2032, USD (Million)
8.4.1.4.2. Opioid Drugs Market: By Application, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Opioid Drugs Market: By Drug, 2022-2032, USD (Million)
8.4.1.5.2. Opioid Drugs Market: By Application, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Opioid Drugs Market: By Drug, 2022-2032, USD (Million)
8.4.1.6.2. Opioid Drugs Market: By Application, 2022-2032, USD (Million)

9. Asia Pacific Opioid Drugs Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Opioid Drugs Market: By Drug, 2022-2032, USD (Million)
9.3. Opioid Drugs Market: By Application, 2022-2032, USD (Million)
9.4.Opioid Drugs Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Opioid Drugs Market: By Drug, 2022-2032, USD (Million)
9.4.1.1.2. Opioid Drugs Market: By Application, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Opioid Drugs Market: By Drug, 2022-2032, USD (Million)
9.4.1.2.2. Opioid Drugs Market: By Application, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Opioid Drugs Market: By Drug, 2022-2032, USD (Million)
9.4.1.3.2. Opioid Drugs Market: By Application, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Opioid Drugs Market: By Drug, 2022-2032, USD (Million)
9.4.1.4.2. Opioid Drugs Market: By Application, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Opioid Drugs Market: By Drug, 2022-2032, USD (Million)
9.4.1.5.2. Opioid Drugs Market: By Application, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Opioid Drugs Market: By Drug, 2022-2032, USD (Million)
9.4.1.6.2. Opioid Drugs Market: By Application, 2022-2032, USD (Million)

10. Latin America Opioid Drugs Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Opioid Drugs Market: By Drug, 2022-2032, USD (Million)
10.3. Opioid Drugs Market: By Application, 2022-2032, USD (Million)
10.4.Opioid Drugs Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Opioid Drugs Market: By Drug, 2022-2032, USD (Million)
10.4.1.1.2. Opioid Drugs Market: By Application, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Opioid Drugs Market: By Drug, 2022-2032, USD (Million)
10.4.1.2.2. Opioid Drugs Market: By Application, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Opioid Drugs Market: By Drug, 2022-2032, USD (Million)
10.4.1.3.2. Opioid Drugs Market: By Application, 2022-2032, USD (Million)

11. Middle East and Africa Opioid Drugs Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Opioid Drugs Market: By Drug, 2022-2032, USD (Million)
11.3. Opioid Drugs Market: By Application, 2022-2032, USD (Million)
11.4.Opioid Drugs Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Opioid Drugs Market: By Drug, 2022-2032, USD (Million)
11.4.1.1.2. Opioid Drugs Market: By Application, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Opioid Drugs Market: By Drug, 2022-2032, USD (Million)
11.4.1.2.2. Opioid Drugs Market: By Application, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Opioid Drugs Market: By Drug, 2022-2032, USD (Million)
11.4.1.3.2. Opioid Drugs Market: By Application, 2022-2032, USD (Million)

12. Company Profile
12.1. Actavis Plc.
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Boehringer Ingelheim
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Endo Pharmaceuticals Inc.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Egalet
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Janssen Pharmaceuticals, Inc.
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Mallinckrodt Pharmaceuticals
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Pfizer Inc.
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Purdue Pharma
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Sanofi
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Sun Pharmaceutical Industries Ltd.
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives